150 results on '"Thyssen, Jacob P"'
Search Results
2. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
3. Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
4. Risk of systemic infections in adults with atopic dermatitis: A nationwide cohort study
5. Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis
6. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis
7. Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
8. 33233 Long-term efficacy (to 68 weeks) of baricitinib in adult patients with moderate to severe atopic dermatitis (AD) who were treatment responders or partial responders and originally included in the combination topical corticosteroids study BREEZE-AD7
9. 34358 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis (AD): Results from an open-label extension (OLE) trial up to 4 years
10. 32496 Efficacy and safety of abrocitinib according to geographies
11. 34599 Achieving incrementally greater skin improvement thresholds with upadacitinib versus dupilumab in moderate-to-severe atopic dermatitis (AD): Heads Up study results
12. 52267 Effectiveness and safety of oral roflumilast in patients with hidradenitis suppurativa: A prospective single-center study
13. 51843 Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa: results from the 700 first patients of the Copenhagen Hidradenitis Suppurativa Cohort Study
14. 51561 The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with disease severity, asthma and rhinitis
15. 51826 PRO-C22 - A Novel Serological Biomarker of Tissue Damage is Associated with Disease Severity, Disease Activity, and Systemic Inflammation in Patients with Hidradenitis Suppurativa
16. 51783 A novel biomarker of type VII collagen degradation is increased in patients with atopic dermatitis and lowered when receiving immunosuppressant treatment.
17. Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis
18. Cause-specific mortality in adults with atopic dermatitis
19. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council
20. Prevalence and risk of migraine in patients with rosacea: A population-based cohort study
21. Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasis
22. Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study
23. The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
24. Autoimmune diseases in adults with atopic dermatitis
25. 52793 Usage of digital information technologies in patients with hidradenitis suppurativa.
26. 52089 Patient characteristics associated with prescription of omalizumab at first visit among hospital outpatients with chronic urticaria.
27. 27603 Rapid itch relief with abrocitinib predicts later skin clearance: A post hoc analysis vs dupilumab and placebo in JADE COMPARE
28. 28032 Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
29. 25442 Relationship between topical corticosteroid utilization and atopic dermatitis severity and burden: A population-based cross-sectional study
30. 25532 Effects of upadacitinib on patient-reported symptoms of atopic dermatitis: Atopic Dermatitis Symptom Scale (ADerm-SS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)
31. 27533 Comparative efficacy and safety of systemic therapies used in adult and adolescent moderate-to-severe atopic dermatitis (AD): A systematic literature review (SLR) and network meta-analysis (NMA)
32. 26292 Rapid improvement in skin pain, and its impact on quality of life, in adult patients with moderate-to-severe atopic dermatitis from a double-blind, placebo-controlled baricitinib phase 3 study
33. 27489 Depth of response to abrocitinib in adults with moderate-to-severe atopic dermatitis (AD): Pooled analysis of monotherapy studies
34. 27237 Effect of abrocitinib vs dupilumab and placebo on patient-reported outcomes (PROs) in moderate-to-severe atopic dermatitis (AD) in JADE COMPARE
35. Anatomical patterns of dermatitis in adult filaggrin mutation carriers
36. 43916 Efficacy and Safety of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the Presence or Absence of Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE
37. 18856 The association between atopic dermatitis and hypertension: A systematic review and meta-analysis
38. Nickel allergy and dermatitis following use of a laptop computer
39. Chronologic order of appearance of immune-mediated inflammatory diseases relative to diagnosis of psoriasis
40. Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis
41. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics
42. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
43. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis
44. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis
45. Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis
46. Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index
47. Association of atopic dermatitis with smoking: A systematic review and meta-analysis
48. 42152 Efficacy of lebrikizumab in patients who did not achieve protocol defined criteria for response after initial 16 weeks of therapy.
49. 43049 Efficacy and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Measure Up 1, Measure Up 2, and AD Up Phase 3 Clinical Trials at 52 Weeks.
50. Assessment of the risk of cardiovascular disease in patients with rosacea
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.